COVID-19: Questions over access raised as vaccine trial kicks off in SA
South African volunteers are about to join the first COVID-19 vaccine trial to be conducted in the country. Ufrieda Ho reports.
South African volunteers are about to join the first COVID-19 vaccine trial to be conducted in the country. Ufrieda Ho reports.
1 October is set to become a memorable day in some higher-education institutions. It marks the day in 2017 that Pre-Exposure Prophylaxis (PrEP) was first rolled out at select campus health clinics as a new, highly effective HIV-prevention method.
Thuthukile Mbatha is a researcher at SECTION27, and an advocacy fellow for the AIDS Vaccine Advocacy Coalition (AVAC). She runs an advocacy project that calls for access to Pre-Exposure Prophlylaxis (PrEP) for young women in higher education institutions.